Emerging photobiomodulation therapeutics

J. Anders

doi:10.1364/CLEO_AT.2017.ATu3A.1

Emerging photobiomodulation therapeutics

J. Anders^*

^*Corresponding author for this work

Anatomy, Physiology, and Genetics

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Abstract

The current status of photobiomodulation therapy will be presented. The importance of device parameters, wavelength selection related to the target tissue, photon dose related to cellular mechanisms, and opportunities for collaboration will be discussed.

Original language	English
Title of host publication	CLEO
Subtitle of host publication	Applications and Technology, CLEO_AT 2017
Publisher	Optica Publishing Group (formerly OSA)
ISBN (Print)	9781943580279
DOIs	https://doi.org/10.1364/CLEO_AT.2017.ATu3A.1
State	Published - 2017
Event	CLEO: Applications and Technology, CLEO_AT 2017 - San Jose, United States Duration: 14 May 2017 → 19 May 2017

Publication series

Name	Optics InfoBase Conference Papers
Volume	Part F43-CLEO_AT 2017
ISSN (Electronic)	2162-2701

Conference

Conference	CLEO: Applications and Technology, CLEO_AT 2017
Country/Territory	United States
City	San Jose
Period	14/05/17 → 19/05/17

Keywords

General: 000.1430 biology and medicine
Medical optics and biotechnology: 170.0170
Medical optics and biotechnology: 170.1610 clinical applications

Access to Document

10.1364/CLEO_AT.2017.ATu3A.1

Cite this

@inproceedings{f3eea4b67be140b497ef9f9e001b14f5,

title = "Emerging photobiomodulation therapeutics",

abstract = "The current status of photobiomodulation therapy will be presented. The importance of device parameters, wavelength selection related to the target tissue, photon dose related to cellular mechanisms, and opportunities for collaboration will be discussed.",

keywords = "General: 000.1430 biology and medicine, Medical optics and biotechnology: 170.0170, Medical optics and biotechnology: 170.1610 clinical applications",

author = "J. Anders",

note = "Publisher Copyright: {\textcopyright} 2017 OSA.; CLEO: Applications and Technology, CLEO\_AT 2017 ; Conference date: 14-05-2017 Through 19-05-2017",

year = "2017",

doi = "10.1364/CLEO\_AT.2017.ATu3A.1",

language = "English",

isbn = "9781943580279",

series = "Optics InfoBase Conference Papers",

publisher = "Optica Publishing Group (formerly OSA)",

booktitle = "CLEO",

}

TY - GEN

T1 - Emerging photobiomodulation therapeutics

AU - Anders, J.

PY - 2017

Y1 - 2017

N2 - The current status of photobiomodulation therapy will be presented. The importance of device parameters, wavelength selection related to the target tissue, photon dose related to cellular mechanisms, and opportunities for collaboration will be discussed.

AB - The current status of photobiomodulation therapy will be presented. The importance of device parameters, wavelength selection related to the target tissue, photon dose related to cellular mechanisms, and opportunities for collaboration will be discussed.

KW - General: 000.1430 biology and medicine

KW - Medical optics and biotechnology: 170.0170

KW - Medical optics and biotechnology: 170.1610 clinical applications

UR - http://www.scopus.com/inward/record.url?scp=85020398265&partnerID=8YFLogxK

U2 - 10.1364/CLEO_AT.2017.ATu3A.1

DO - 10.1364/CLEO_AT.2017.ATu3A.1

M3 - Conference contribution

AN - SCOPUS:85020398265

SN - 9781943580279

T3 - Optics InfoBase Conference Papers

BT - CLEO

PB - Optica Publishing Group (formerly OSA)

T2 - CLEO: Applications and Technology, CLEO_AT 2017

Y2 - 14 May 2017 through 19 May 2017

ER -

Emerging photobiomodulation therapeutics

Abstract

Publication series

Conference

Keywords

Access to Document

Fingerprint

Cite this